Related Experiment Video
Updated: Feb 12, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Prediction of Functional Outcomes at Discharge Using Plasma Concentration of von Willebrand Factor Antigen at
Masayuki Oki1, Daisuke Yamasawa1, Shinichi Goto1
1Division of General Internal Medicine and Family Medicine, Department of General and Acute Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Insights
Elevated von Willebrand factor (VWF) levels at hospital admission predict poor functional outcomes in patients with Coronavirus disease 2019 (COVID-19) after discharge. This finding is independent of patient age and sex.
Area of Science:
- Vascular Medicine
- Immunothrombosis
- Biomarkers
Background:
- Coronavirus disease 2019 (COVID-19) can cause endothelial injury, leading to vascular dysfunction and immunothrombosis.
- Plasma von Willebrand factor (VWF) levels are recognized biomarkers of vascular injury.
- The predictive value of VWF for post-discharge functional outcomes in COVID-19 patients is not well-established.
Purpose of the Study:
- To investigate the association between plasma VWF antigen (VWF:Ag) levels at hospital admission and functional status at discharge in COVID-19 patients.
- To determine if VWF:Ag is an independent predictor of poor functional outcomes post-discharge.
Main Methods:
- A single-center prospective cohort study was conducted with 97 hospitalized COVID-19 patients.
- Plasma VWF:Ag levels were measured at admission.
- Functional status at discharge was assessed using the Clinical Frailty Scale (CFS).
- Univariable and multivariable logistic regression analyses were employed.
Main Results:
- The median VWF:Ag level at admission was 330.0%.
- Elevated VWF:Ag levels were significantly associated with a CFS score ≥4 at discharge in univariable analysis.
- This association remained statistically significant after adjusting for age and sex (OR 1.010, p=0.005).
Conclusions:
- Elevated plasma VWF:Ag levels at admission are a significant predictor of poor functional outcomes at discharge in COVID-19 patients.
- VWF:Ag serves as an independent prognostic biomarker for functional recovery after COVID-19 hospitalization.
- These findings highlight the role of VWF in COVID-19-related vascular injury and long-term outcomes.
Objectives:
Coronavirus disease 2019 (COVID-19) causes endothelial injury through inflammatory and hypoxic stress, leading to vascular dysfunction and immunothrombosis. The plasma level of von Willebrand factor (VWF) could serve as a biomarker of vascular injury. While elevated VWF predicts mortality in severe COVID-19, its relationship with post-discharge functional outcomes remains unclear. This study aimed to determine whether plasma VWF antigen (VWF:Ag) levels at admission predict functional status at discharge in patients hospitalized for COVID-19.
Methods:
This was a single-center prospective cohort study conducted at Tokai University Hospital from July to September 2021. We evaluated the relationship between plasma VWF:Ag levels at admission and a Clinical Frailty Scale (CFS) score ≥4 at discharge using univariable and multivariable logistic regression analyses.
Results:
A total of 97 patients were enrolled in the study. The median VWF:Ag level at admission was 330.0% (95% confidence interval [CI]: 273.0-391.8). Univariable analysis showed a significant association between elevated VWF:Ag levels and CFS score ≥4 at discharge. This association remained significant after adjusting for age and sex (odds ratio 1.010, 95% CI: 1.000-1.010, p = 0.005).
Conclusion:
Elevated VWF:Ag levels at admission predict poor functional outcomes at discharge in COVID-19 patients, independent of age and sex.
More Related Videos
Related Concept Videos
Predicting Reaction Outcomes
Hospitals-II
Nurses that work in...
Hospitals-I
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
RC Circuits: Discharging A Capacitor

